Hello Health Rounds readers. Today we feature a pair of studies that took a deeper dive into the effects of GLP-1 drugs being widely used for weight loss and diabetes.
NEW YORK, March 2, 2026 /PRNewswire/ -- Bracha Banayan, FNP, founder of Hello Dose and IVDrips, has launched Hello Dose, a telehealth platform offering clinician-supervised GLP-1 medication management ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results